Abbott Laboratories (ABT) Faces Class-Action Lawsuit Over PediaSure
Published on 6/27/2026

AI Summary
Summarized by AI from the source belowA federal judge ruled that Abbott Laboratories (ABT) must face a class-action lawsuit regarding allegations it misled consumers about PediaSure Grow & Gain drinks being 'clinically proven' for children's growth. The lawsuit claims the marketing could mislead consumers into interpreting growth as height gain, while using labels suggesting weight gain. Plaintiff Joanne Noriega alleges her grandson remained short after a year of daily use. Abbott maintains its labeling is appropriate and evidence-based, stating PediaSure supports children's growth and development.
Get the free market brief
Top stories and analysis, summarized. No spam, unsubscribe anytime.
Related News

Regulation
Equifax (EFX) Settles for $2.2 Million Over Credit Report Errors
Aug 11

Regulation
Goldman (GS) Executives Accused of Fraud in Oncoclinicas Tender Offer
Aug 10

Regulation
Trump Orders Reduction to 11 Childhood Vaccines Amid Autism Claims
Aug 10

Regulation
Fortis (TSX:FTS) Examines Rate Pressure on Financial Stability
Aug 10